OCT 30, 2014 12:00 PM PDT

The metabolic microenvironment in tumors and its impact on T-cell mediated immunity

Speaker
  • Scientist BC Cancer Agency's Deeley Research Centre, Assistant Professor Department of Biochemistry and Microbiology, University of Victoria
    BIOGRAPHY

Abstract

It has become widely accepted that the presence of intraepithelial CD8+ T cell correlate with improved patient survival. In contrast, tumors largely devoid of immune infiltrations or infiltrates skew towards a suppressive phenotype are associated with poor outcomes. In this talk, I will discuss the metabolic constraints imposed by the tumor microenvironment and how this may impact T cell responses against tumors. Specific emphasis will be placed on the condition of hypoxia, its role in the regulation of T cell differentiation, effector function and survival. Initially using ovarian cancer as a disease site, our recently work shows that the tumor microenvironment plays a significant role in dictating the presence and function of T cells. We used a multi-parameter immunohistochemical staining system to co-identify markers of the tumor vasculature and the relative expression of T cells within these regions. We find few T cells co-localizing to areas of hypoxia, whereas most T cells are present in areas of high vascularity. Moreover, there was an association towards improved survival when T cells were detected in vascular environments of the tumor. These observations are consistent with our in vitro work showing that T cells undergoing hypoxia-induced autophagy have impaired cytolytic activity. Overall, this indicates that a T cell response requires overcoming the barriers of the metabolic tumor environment and this may have important implications for T cell-based therapies for the treatment of cancer.


Show Resources
You May Also Like
AUG 16, 2022 11:00 AM PDT
AUG 16, 2022 11:00 AM PDT
Date: August 16, 2022 Time: 11:00am (PDT), 2:00pm (EDT), 8:00pm (CEST) Understanding genomic variation in the context of cancer is paramount to identifying disease drivers and informing pers...
MAY 17, 2022 9:00 AM PDT
MAY 17, 2022 9:00 AM PDT
Date: May 17, 2022 Time: 9:00am (PDT), 12:00pm (EDT), 8:00pm (CEST) Gene therapeutics have great potential to treat many severe diseases in an unprecedented, targeted manner. The biopharmace...
JUN 21, 2022 6:00 AM PDT
JUN 21, 2022 6:00 AM PDT
Date: June 21, 2022 Time: 6:00am (PDT), 9:00am (EDT), 3:00pm (CEST) The global understanding and practice of medicine is currently undergoing a revolutionary change. This shift to precision...
SEP 22, 2022 9:00 AM PDT
SEP 22, 2022 9:00 AM PDT
Date: September 22, 2022 Time: 9:00am (PDT), 12:00pm (EDT), 6:00pm (CEST) Optimizing platforms for surgical specimen collection and deep human phenotyping was used to enhance protein biomarke...
JUN 28, 2022 7:00 AM PDT
JUN 28, 2022 7:00 AM PDT
Date: June 28, 2022 Time: 3:00pm (BST), 4:00pm (CET), 9:00am (CST), 7am (PST) Light-sheet microscopy is an extremely versatile imaging technique with a vast range of implementations that are...
SEP 29, 2022 8:00 AM PDT
SEP 29, 2022 8:00 AM PDT
Date: September 29, 2022 Time: 8:00am (PDT), 11:00am (EDT), 5:00pm (CEST) Adeno-associated virus (AAV) is one of the most widely used delivery vehicles in gene therapy. To ensure the safety...
OCT 30, 2014 12:00 PM PDT

The metabolic microenvironment in tumors and its impact on T-cell mediated immunity



Show Resources
Loading Comments...
Show Resources